Oric Pharmaceuticals

ORIC

Börsenwert 1,41 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Fidelity Investments Boston, Massachusetts	13,9 Mio. $	-27.182 $	-6.790	-0,2 %
2	2 Column Group San Francisco, California	11,4 Mio. $	–	–	–
3	3 EcoR1 Capital San Francisco, California	10,9 Mio. $	–	–	–
4	4 Alkeon Capital Management New York	6,74 Mio. $	–	–	–
5	5 OrbiMed New York	6,68 Mio. $	–	–	–
6	6 Suvretta Capital Management New York	6,09 Mio. $	+2,56 Mio. $	+640.179	+51 %
7	7 Millennium Management New York	4,89 Mio. $	+346.810 $	+86.631	+6 %
8	8 Vanguard Group Malvern, Pennsylvania	4,31 Mio. $	-267.697 $	-66.869	-5 %
9	9 Silverarc Capital Management Boston, Massachusetts	3,87 Mio. $	+507.170 $	+126.688	+12 %
10	10 Boxer Capital San Diego, California	3,37 Mio. $	–	–	–
11	11 BlackRock New York	3,32 Mio. $	+959.195 $	+239.601	+30 %
12	12 Invus Financial Advisors New York	3,22 Mio. $	–	–	–
13	13 Prosight Management Dallas, Texas	3 Mio. $	+3,75 Mio. $	+936.334	Neu
14	EC 14 Euclidean Capital New York	2,39 Mio. $	–	–	–
15	15 Memorial Sloan Kettering Cancer Center New York	1,93 Mio. $	–	–	–
16	16 ArrowMark Colorado Holdings Denver, Colorado	1,74 Mio. $	-2,96 Mio. $	-739.346	-58 %
17	17 D.E. Shaw & Co New York	1,71 Mio. $	+111.696 $	+27.901	+6 %
18	18 DAFNA Capital Management Los Angeles, California	1,32 Mio. $	-9.608 $	-2.400	-0,6 %
19	19 Renaissance Technologies New York	1,28 Mio. $	-186.029 $	-46.469	-10 %
20	AG 20 Artal Group Luxembourg	1,28 Mio. $	–	–	–
21	21 UBS O'Connor Chicago, Illinois	1,1 Mio. $	-72.272 $	-18.053	-5 %
22	22 Monaco Asset Management Monaco	1,09 Mio. $	-94.314 $	-23.559	-6 %
23	23 Geode Capital Management Boston, Massachusetts	909.000 $	-160.392 $	-40.065	-12 %
24	24 Oasis Management Company Grand Cayman, Cayman Islands	872.000 $	–	–	–
25	25 GSA Capital Partners London, United Kingdom	722.000 $	+700.437 $	+174.965	+346 %

Oric Pharmaceuticals ORIC Börsenwert 1,41 Mrd. $

Oric Pharmaceuticals

ORIC

Börsenwert 1,41 Mrd. $